CilentoDx GmbH

Bahnhofstraße 10, 16556 Hohen Neuendorf, DEU

Master Data

Basic information of the organization

Registry

Registered

3/26/2024

IndustryClassified using Destatis WZ standard, derived from commercial register and web data by Fusionbase AI.

Research and experimental development on biotechnologyResearch and experimental development on biotechnologyWZ 72.10.1PrimaryManufacture of irradiation, electromedical and electrotherapeutic equipmentManufacture of irradiation, electromedical and electrotherapeutic equipmentWZ 26.60.0Manufacture of testing machinesManufacture of testing machinesWZ 26.51.3

Purpose

Die Entwicklung und Vermarktung von Diagnostika in der Präventionsmedizin.

History

Changes published in the official company registry

No events found for this filter

Management

Legal representatives of the organization

Name	Role	Entry Date
Metod Dr. Miklus since 4/26/2024	Managing Director	4/26/2024
Anja Edelgard Hannover Schmarsow since 3/26/2024	Managing Director	3/26/2024

Beneficial Owners

Natural persons who ultimately own or control the company, resolved through the shareholder chain

Beneficial owner data is only accessible to registered users.

Shareholders

Company ownership and partner structure

3 shareholders

GmbH structure

2 of 3 shown

NeuroPep GmbH

Germany

€30,000

75.00%

Exponat Verwaltungsgesellschaft mbH

Germany

€5,000

12.50%

News & Media Coverage

Insolvency Notices

Real-time check for insolvency notices from register courts

Current insolvency proceedings

Check if there are any insolvency proceedings for this company

Commercial Register Documents

Real-time document download from the commercial register

Shareholder List

Current Print (Aktueller Abdruck)

Chronological Print (Chronologischer Abdruck)